Chemical Structure (01)
Decitabine Injection, Powder, Lyophilized, For Solution
Product Images NDC 67184-0535
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Decitabine (NDC 67184-0535). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Qilu Pharmaceutical Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Decitabine For Injection Vial Label (02)
This is a description of a medication called Decitabine for Injection, with each vial containing 50 mg of the drug. The manufacturer is WZ Pharmaceutical (Hainan) Co., Ltd in Haikou, China. The vial also contains potassium phosphate, and sodium hydroxide. The medication is for single-use only, and any unused portion should be discarded. The vials should be stored at a temperature between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). More information is available about the indications, dosage, and precautions that should be taken.*
Decitabine For Injection Carton Label (03)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
